Pharmacokinetics and organ distribution of cationized colchicine- specific IgG and Fab fragments in rat

Journal of Pharmaceutical Sciences

Volumn 88, Issue 1, 1999, Pages 147-153

  Hong, Guiying ^a,b   Bazin Redureau, Martine I ^a   Scherrmann, Jean Michel G ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL FERNAND WIDAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; COLCHICINE; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; PROTEIN; TRICHLOROACETIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEIODINATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG UPTAKE; IMMUNOPRECIPITATION; MALE; MOLECULAR SIZE; NONHUMAN; ORGAN DISTRIBUTION; PROTEIN ANALYSIS; RADIOIODINATION; RAT;

EID: 0032904706     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js970335n     Document Type: Article

References (42)

1. Waldmann, T. A. Monoclonal Antibodies in Diagnosis and Therapy, Science 1991, 252, 1657-1662.
2. Scherrmann, J. M.; Urtizberea, M.; Pierson; P.; Terrien, N. The Effect of Colchicine-Specific Active Immunization on Colchicine Toxicity and Disposition in the Rabbit. Toxicology 1989, 56, 213-222.
3. Brady, L. W.; Markoe, A. M.; Woo, D. V. Iodine-125-labeled Anti-epidermal Growth Factor Receptor-425 in the Treatment of Glioblastoma Multiforme. A Pilot Study. Radiat. Ther. Oncol. 1990, 24, 151-160.
4. Jain, R. K. Tumor Physiology and Antibody Delivery. Radiat. Ther. Oncol. 1990, 24, 32-46.
5. Pardridge, W. M. Absorptive-Mediated Transcytosis of Peptides Through the Blood-Brain Barrier. In Peptide Drug Delivery to the Brain; Raven: New York, 1991; pp 189-218.
6. Triguero, D.; Buciak, J. L.; Pardridge, W. M. Blood-Brain Barrier Transport of Cationized Immunoglobulin G. Enhanced Delivery Compared to Native Protein. Proc. Natl. Acad. Sci., U.S.A. 1989, 56, 4761-4765.
7. Triguero, D.; Buciak, J. L.; Pardridge, W. M. Cationization of Immunoglobulin G Results in Enhanced Organ Uptake of the Protein after Intravenous Administration in Rats and Primate. J. Pharmacol. Exp. Ther. 1991, 225, 186-192.
8. Pardridge, W. M. Transport of Small Molecules through the Blood-brain Barrier: Biology and Methology. Adv. Drug Delivery Rev. 1995, 15, 5-36.
9. Chappey, O. L.; Niel, E.; Debray, M.; Wautier, J. L.; Scherrmann, J. M. Efflux of Intracellular Colchicine in Lymphocytes with Colchicine-specific Fab Fragments. J. Pharmacol. Exp. Ther. 1995, 274, 1072-1076.
10. Sabouraud, A. E.; Urtizberea, M.; Benmoussa, K. Fab-bound Colchicine Appears to Adopt Fab Fragment Disposition in Rats. J. Pharm. Pharmacol. 1992, 44, 1015-1019.
11. Pardridge, W. M.; Bickel, U.; Buciak, J.; Yang, J.; Diagne, A.; Aepinus, C. Cationization of a Monoclonal Antibody to the Human Immunodeficiency Virus REV Protein Enhances Cellular Uptake but Does Not Impair Antigen Binding of the Antibody. Immunol. Lett. 1994, 42, 191-195.
12. 4 Nature (London) 1970, 277, 680-685.
13. Müller, R. Calculation of Average Antibody Affinity in Anti-Hapten Sera from Data Obtained by Competitive Radioimmunoassay. J. Immunol. Meth. 1980, 34, 345-352.
14. Fraker, P. J.; Speck, J. C. Protein and Cell Membrane Iodinations with a Sparingly Soluble Chloramide 1,3,4,6-Tetrachloro-3a, 6a-Diphenylglycoluril. Biochem. Biophys. Res. Commun. 1978, 80, 849-857.
15. Pardridge, W. M. Carrier-Mediated Transport of Thyroid Hormones Through the Blood-Brain Barrier. Primary Role of Albumin-Bound Hormone. Endocrinology 1979, 105, 605-612.
16. Ebling, W. F.; Wada, D. R.; Stanski, D. R. From Piecewise to Full Physiologic Pharmacokinetic Modeling: Applied to Thiopental Disposition in the Rat. J. Pharmacokinet. Biopharm. 1994, 22 (4), 259-292.
17. Gibaldi, M.; Perrier, D. In Pharmacokinetics; Gibaldi, M.; Perrier, D.; Eds.; Dekker: New York, 1982.
18. Smith, K. R.; Borchardt, R. T. Permeability and Mechanism of Albumin, Cationized albumin, and Glycosylated Albumin Transcellular Transport Across Monolayers of Cultured Bovine Brain Capillary Endothelial cells. Pharm. Res. 1989, 6, 466-473.
19. Williams, S. K.; Devenny, J. J.; Bitensky, M. W. Micropinocytic Ingestion of Glycosylated Albumin by Isolated Microvessels: Possible Role in Pathogenesis of Diabetic Microangiopathy. Proc. Natl. Aacad. Sci., U.S.A. 1981, 78, 2393-2397.
20. Chekhonin, V. P.; Ryabukhin, I. A.; Zhirkov, Y. A. Transport of Hydrophobized Fragments of Antibodies through the Blood-Brain Barrier. Neuroreport 1995, 129-132.
21. Mulcahy, L. S.; Smith, M. R.; Stacey, D. W. Requirement for Ras Proto-Oncogene Function during Serum-Stimulated Growth of NIH 3t3 Cells. Nature 1985, 313, 241-243.
22. Bauer, R. J.; Leigh, S. D.; Birr, C. A.; Bernhard, S. L. Alteration of the Pharmacokinetics of Small Proteins by Iodination. Biopharm. Drug. Dispos. 1996, 17, 761-774.
23. Kuo, B.; Nordblom, G. D.; Wright, D. S. Pertubration of Epidermal Growth Factor Clearance after Radioiodination and Its Implication. J. Pharm. Sci. 1997, 86 (13), 290-296.
24. Bergmann, P.; Kacenelenbogen, R.; Vizet, A. Plasma Clearance, Tissue Distribution and Catabolism of Cationized Albumins with Increasing Isoelectric Points in the Rat. Clin. Sci. 1984, 67, 35-43.
25. Pepin, S.; Lutsch, C.; Grandgeorge, M.; Scherrmann, J. M. Snake F(ab′)2 Antivenom from Hyperimmunized Horse: Pharmacokinetics Following Intravenous and Intramuscular Administrations in Rabbits. Pharm. Res. 1995, 12 (10), 1-4.
26. Muckerheide, A.; Domen, P. L.; Michael J. G. Cationisation of Protein Antigens. II. Alteration of regulatory properties. J. Immunol. 1987, 138 (9), 2800-2804.
27. Apple, R. J.; Domen, P. L.; Muckerheide, A.; Michael J. G. Cationisation of Protein Antigens. III. Increased Antigen Uptake by Antigen-Presenting Cells. J. Immunol. 1988, 140 (10), 3290-3295.
28. Pardridge, W. M.; Triguero, D.; Buciak, J. L.; Yang, J. Evaluation of Cationized Rat Albumin as a Potential Blood-Brain Barrier Drug Transport Vector. J. Pharmacol. Exp. Ther. 1990, 255 (2), 893-899.
29. Pardridge, W. M.; Kang, Y.; Yang, J.; Buciak, J. L. Enhanced Cellular Uptake and in vivo Biodistribution of a Monoclonal Antibody Following Cationization. J. Pharm. Sci. 1995, 84, 943-948.
30. Pentel, P. K.; Keyler, D. E.; Gilbertson, D. G.; Ruth, G.; Pond, S. M. Pharmacokinetics and Toxicity of High Doses of Antibody Fab Fragments in Rats. Drug Metab. Dispos. 1988, 16, 141-145.
31. McClurkan, M. B.; Valentine, J. L.; Arnold, L., Owens; S. M. Disposition of Monoclonal Anti-phencyclidine Fab Fragments of Immunoglobulin G in Rats. J. Pharmacol. Exp. Ther. 1993, 266, 1439-1445.
32. Bazin-Redureau, M. I.; Renard, C. B.; Scherrmann, J. M. G. Pharmacokinetics of Heterologous and Homologous Immunoglobulin G, F(ab′)2 and Fab after Intravenous Administration in the Rat. J. Pharm. Pharmacol. 1997, 49, 277-281.
33. Pardridge, W. M.; Buciak, J. L.; Friden, P. M. Selective Transport of an Anti-Transferrin Receptor Antibody through the Blood-Brain Barrier. J. Pharmacol. Exp. Ther. 1991, 252, 1247-1254.
34. Pardridge, W. M.; Kang, Y.; Diagne, A.; Zack, J. A. Cationized Hyperimmune Immunoglobulins: Pharmacokinetics, Toxicity Evalution and Treatment of Human Immunodeficiency Virus-Infected Human-Peripheral Blood Lymphocytes-Severe Combined Immune Deficiency Mice. J. Pharmacol. Exp. Ther. 1996, 276, 246-252.
35. Hong, G.; Bazin-Redureau, M. I.; Scherrmann, J. M. G. Hepatic Disposition and Toxicity of Cationized Goat Immunoglobulin G and Fab Fragments in Isolated Perfused Rat Liver. Drug Metab. Dispos., in press.
36. Takakura, Y.; Fujita, T.; Hashida, M.; Sezaki, H. Disposition Characteristics of Macromolecules in Tumor-Bearing Mice. Pharm. Res. 1990, 7, 339-346.
37. Praaning-van Dalen, D. P.; Brouwer, A.; Knook, D. L. Clearance Capacity of Rat Liver Kupffer, Endothelial, and Parenchymal Cells. Gastroenterology 1981, 81(6), 1036-1044.
38. Meiger, D. K. F.; Mol, W. E. M.; Muller, M.; Kurz, G. Carrier-mediated Transport in the Hepatic Distribution and Elimination of Drugs, with Special Reference to the Category of Organic Cations. J. Pharmacokinet. 1990, 18, 35-70.
39. Taylor, A. E.; Granger, N. D. Exchange of Macromolecules Across the Microcirculation; In Handbook of Physiology: the Cardiovascular System, Section 2, Volume IV; Renkin, E. M.; Michel, C. C., Eds.; American Physiology Society: Bethesda, MD, 1984; pp 467-520.
40. Brenner, B. M.; Hostetter, T H.; Humes, H. D. Glomerular Permeselectivity: Barrier Function Based on Discrimination of Molecular Size and Charge. Am. J. Physiol. 1978, 234, 7455-7460.
41. Arend, W. P.; Silverblatt, F. J. Serum Disappearance and Catabolism of Homologous Immunoglobulin Fragments in Rats. Clin. Exp. Immunol. 1975, 22 (3), 502-513.
42. Rochdi, M.; Sabouraud, A.; Baud, F. J.; Bismuth, C.; M., S. J. Toxicokinetics of Colchicine in Humans: Analysis of Tissue, Plasma and Urine Data in Ten Cases. Hum. Exp. Toxicol. 1992, 11, 510-516.